
The 2019 Gordon Research Conference on Stem Cells and Cancer will bring together a diverse, interdisciplinary group of researchers with interests in organogenesis, tumorigenesis, stem cell function and therapy to catalyze collaboration and cross-fertilize ideas. The meeting will focus particularly on developmental, metabolic, genomic and epigenomic mechanisms regulating the function of cancer cells and stem cells. We will explore exciting new opportunities and insights available from genome-wide genetic and epigenetic studies, now with single cell resolution, from high resolution assessment of mitochondrial bioenergetics and metabolic flux, and from the increased experimental accessibility of stem cell differentiation and tumorigenic processes made possible by induced pluripotency, direct reprogramming and ex vivo “organoid” cultures. Finally, we will discuss new and emerging clinical applications, rooted in concepts derived from the interface of cancer and stem cell biology, providing a window into future cutting-edge therapies for cancer and degenerative disease.
SY-Stem – a symposium focusing on the next generation of stem cell researchers – is an annual meeting, located in the beautiful city of Vienna. It is organized jointly by the Research Institute of Molecular Pathology (IMP) and Institute of Molecular Biotechnology (IMBA). In this two-and-a-half-day event, recognized keynote speakers, as well as aspiring young group leaders will discuss the latest advances in stem cell biology in an informal and collaborative setting. Our goal is to strengthen a cooperative and dynamic spirit in this research area.
The first isolation of embryonic stem cells in 1981 brought the promise of effective treatments for conditions from heart disease to spinal cord injury to diabetes. Unfortunately, despite intense research, few viable stem cell-based therapies have emerged over the last 30 years. More recently, significant progress has been made in understanding stem cell niches and factors governing homing, activation and differentiation of adult stem cells fueling hope of second-generation stem cell therapies. This interdisciplinary symposium will convene leading experts in the fields of adult stem cell research, tissue regeneration and bioengineering to discuss cutting edge research with an emphasis on strategies for clinical translation.
Conference Series LLC Ltd invites all the participants from all over the world to attend the 13th Annual Conference on Stem Cell & Regenerative Medicine, March 11-12, 2019 in Nice, France which includes keynote presentations, workshops, poster presentations, exhibitions and oral talks. The conference will focus on the theme “Stem Cells: A Novel Approach towards Regenerative Medicine.”
This laboratory-based training course will provide a comprehensive overview of the theory and practical laboratory skills required for the genetic manipulation of mammalian stem cells, focusing on human iPS cells. Genome informatics, vector construction and genome editing strategies using CRISPR-Cas9 will be covered in interactive practicals and demonstrations, with discussions and lectures by international experts.
To honor patients with rare diseases and their families, Rocket Pharmaceuticals, Inc., The Alexandria Center for Life Science and the RTW Charitable Foundation are sponsoring a patient-centered educational event, to promote a greater understanding within the NYC-based biotech community of the daily challenges faced by patients and families.
Transforming Innovative Research to Change the Shape of Cell Therapy Manufacturing in Asia and Beyond.
World-renowned scientists sharing the latest technologies, R&D and clinical data to fast-track your next-generation cell and gene therapies towards commercial success.
Immerse yourself in the Asia Cell Therapy Market by attending the Cell Therapy Manufacturing Asia event in February 2019.
Join other policy and healthcare innovation leaders to grasp the challenges and explore solutions to making cures accessible to patients and sustainable by the healthcare system.
Registration is free but seating is extremely limited. Please reserve your seat today.
See the agenda and learn more at http://payingforcures.org – Hosted by MIT Center for Biomedical Innovation NEWDIGS Initiative.